About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
16
As Collaborator
0
Total Enrollment
3,789
By Phase
PHASE1: 12PHASE4: 1PHASE3: 2PHASE2: 1
By Status
COMPLETED: 15RECRUITING: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06498284Lead Sponsor
Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus
PHASE1Completed
40 participants
Started: Apr 25, 2024 · Completed: Sep 6, 2024
NCT06263348Lead Sponsor
A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes
PHASE4Recruiting
2,000 participants
Started: Dec 20, 2023 · Completed: Apr 30, 2026
NCT04324424Lead Sponsor
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers
PHASE1Completed
17 participants
Started: Apr 23, 2019 · Completed: Sep 30, 2019
NCT03790787Lead Sponsor
Drug Interaction Study Between Dorzagliatin and Empagliflozin
PHASE1Completed
16 participants
Started: Apr 18, 2019 · Completed: Mar 15, 2020
NCT04426708Lead Sponsor
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers
PHASE1Completed
25 participants
Started: Feb 18, 2019 · Completed: Jul 3, 2020
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...